STSN (Stemsation International) EBITDA Margin %: -6,700.00% (As of Sep. 2011)


What is Stemsation International EBITDA Margin %?

Stemsation International STSN -12.20% EBITDA Margin % is -6,700.00% as of Sep. 2011.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Stemsation International's EBITDA for the three months ended in Sep. 2011 was $-0.07 Mil. Stemsation International's Revenue for the three months ended in Sep. 2011 was $0.00 Mil. Therefore, Stemsation International's EBITDA margin for the quarter that ended in Sep. 2011 was -6,700.00%.

Stemsation International  (OTCPK:STSN) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Stemsation International EBITDA Margin % Related Terms

Stemsation International EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Stemsation International's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stemsation International EBITDA Margin % Chart

Stemsation International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
EBITDA Margin %
0.00 0.00 0.00 0.00 -4,466.67

Stemsation International Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2,600.00 -2,500.00 -9,600.00 0.00 -6,700.00

STSN vs MAMP, LODE: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Stemsation International's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Stemsation International EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Stemsation International's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Stemsation International's EBITDA Margin % falls into.


Stemsation International EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Stemsation International's EBITDA Margin % for the fiscal year that ended in Dec. 2010 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2010 )/Revenue (A: Dec. 2010 )
=-0.134/0.003
=-4,466.67 %

Stemsation International's EBITDA Margin % for the quarter that ended in Sep. 2011 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2011 )/Revenue (Q: Sep. 2011 )
=-0.067/0.001
=-6,700.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -6,700.00% mean?
Stemsation International (STSN) has a EBITDA Margin % of -6,700.00% as of Sep. 2011. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Stemsation International and its competitors.
Is Stemsation International's EBITDA Margin % too high?
Stemsation International's current EBITDA Margin % is -6,700.00%.
How does Stemsation International's EBITDA Margin % compare to MAMP and LODE?
Stemsation International's EBITDA Margin % of -6,700.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Stemsation International and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Stemsation International's current EBITDA Margin % is -6,700.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stemsation International stock overvalued right now?
Stemsation International (STSN) has a current EBITDA Margin % of -6,700.00%. The current EBITDA Margin % is -6,700.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Stemsation International (STSN), the current EBITDA Margin % is -6,700.00% as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stemsation International Business Description

Address 9555 Bergamot Street, Lake Worth, FL, USA, 33467
Stemsation International Inc is developing a line of canned, flavored oxygen products to be sold business-to-business (B2B) and direct to consumers (DTC). These products will be distributed to the beverage industry, as well as to restaurants and bars. It is also developing R&D and manufacturing relationships for additional products and services.